"Cisapride" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
Descriptor ID |
D020117
|
MeSH Number(s) |
D02.065.277.135 D02.241.223.100.050.500.700 D02.241.223.100.100.135 D02.241.223.100.200.374 D02.455.426.559.389.127.020.937.700 D02.455.426.559.389.127.085.135 D02.455.426.559.389.127.250.374 D03.383.621.135
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cisapride".
Below are MeSH descriptors whose meaning is more specific than "Cisapride".
This graph shows the total number of publications written about "Cisapride" by people in this website by year, and whether "Cisapride" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1998 | 0 | 1 | 1 |
1999 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cisapride" by people in Profiles.
-
Clinical inquiries: what is the role of prokinetic agents for constipation? J Fam Pract. 2009 Apr; 58(4):220d-220f.
-
Cisapride 20 mg b.d. for preventing symptoms of GERD induced by a provocative meal. The CIS-USA-89 Study Group. Aliment Pharmacol Ther. 1999 Jun; 13(6):787-94.
-
Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group. Am J Gastroenterol. 1998 Apr; 93(4):547-52.
-
Dystonic-like reaction following cisapride therapy. J Fam Pract. 1995 Jan; 40(1):86-8.